William Olsen

Arnall Golden Gregory LLP

+ Follow Contact

Latest Posts › Coronavirus/COVID-19

Share:

Risk Mitigation for Companies Facing Increased Antitrust Oversight in a Post-Pandemic Environment

Since March 2020, as a result of the COVID-19 pandemic, many businesses have been forced, by local, state, and federal orders, and/or economic circumstances, to alter, reduce, or cease operations. As the business landscape...more

1/20/2021 / Budget Cuts , Business Interruption , Collusion , Compliance , Coronavirus/COVID-19 , Fraud , Investigations , Risk Mitigation

AGG Food & Drug Newsletter - July 2020

Arnall Golden Gregory LLP's Food and Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of AGG outside the Food and Drug practice....more

7/29/2020 / Cannabidiol (CBD) oil , Clinical Trials , Coronavirus/COVID-19 , Food and Drug Administration (FDA) , Life Sciences , Medical Devices , Misbranding , Pharmaceutical Industry , Prescription Drugs

Mitigating Fraud and Corruption Risks During the COVID-19 Crisis

Fraud and corruption thrive in chaos. The COVID-19 pandemic and its economic destabilization create the conditions in which misconduct can thrive....more

3/26/2020 / Anti-Fraud Provisions , Compliance , Coronavirus/COVID-19 , Corruption , Foreign Commerce , Fraud and Abuse , Fraud Prevention , Office of Foreign Assets Control (OFAC) , Trading with the Enemy Act

3 Results

View per page

Page: of 1